NCT01905046 2025-04-13
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00984490 2024-02-01
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT01101438 2023-09-13
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT02028221 2023-06-27
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
University of Arizona
Phase 2 Completed
NCT00930579 2022-10-20
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Phase 2 Completed
NCT01310231 2021-04-14
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Ozmosis Research Inc.
Phase 2 Completed
NCT01627067 2020-06-19
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01302379 2020-06-05
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
University of California, San Diego
Phase NA Completed
NCT02472353 2019-10-16
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Phase 2 Terminated
NCT01340300 2018-06-06
Exercise and Metformin in Colorectal and Breast Cancer Survivors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated